A fifty-four-year-old woman became the first person to simultaneously receive a gene-edited pig kidney transplant and mechanical heart valve implantation. Surgeons performed the heart pump procedure first before performing the transplant days later.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Mechanical circulatory assistance
May 2, 2024
April 18, 2024
This study aimed to describe the use of perioperative mechanical circulatory support (MCS) and its impact on outcomes in patients with ischemic cardiomyopathy undergoing surgical revascularization.
April 16, 2024
CTSNet Global Editor Emily Farkas spoke with Professor Rawn Salenger about his strategy for achieving a low perfusion rate when performing CABG surgery.
January 23, 2024
Interesting conclusion on superiority of CRT over ICD
January 17, 2024
This review explores the application of invasive hemodynamic assessments in the personalization of care for patients with left ventricular assist devices (LVADs).
January 11, 2024
In this article, the author describes three patients who had undergone previous mitral and aortic valve replacement, experiencing cardiogenic shock due to valve dysfunction. The initial evaluation demonstrated that the patients were deemed inoperable based on risk score calculations.
November 28, 2023
This video is the third-place winner from CTSNet’s 2023 Innovation Video Competition. Watch all entries into the competition, including the other winning videos.
November 16, 2023
Patients younger than nineteen years old were included in a study developed to gain a better understanding of pediatric patients supported with ventricular assist devices (VADs). The authors found that illness at VAD implantation, diagnosis, and strategy of support affect survival and differ by device type.
Veno-Arterial ECMO for Circulatory Failure in COVID-19 Patients: Insights from the ECMOSARS Registry
November 16, 2023
ECMOSARS registry data was used to describe the characteristics and outcomes of COVID-19 patients undergoing either veno-arterial (VA) or veno-arterial venous (VAV) extracorporeal membrane oxygenation (ECMO).